Derivation of fully functional chemically reprogrammed liver progenitors (CLiPs) from adult hepatocytes or iPS cells towards hepatocyte transplantation therapy

Project Details

StatusFinished
Effective start/end date1/01/24 → 30/09/24

Funding

  • Novo Nordisk: £42,865.76